Windward Capital Management Co. CA Decreases Stake in CVS Health Co. (NYSE:CVS)

Windward Capital Management Co. CA decreased its holdings in CVS Health Co. (NYSE:CVS) by 1.5% during the 2nd quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 291,749 shares of the pharmacy operator’s stock after selling 4,547 shares during the quarter. CVS Health makes up 1.5% of Windward Capital Management Co. CA’s portfolio, making the stock its 23rd biggest position. Windward Capital Management Co. CA’s holdings in CVS Health were worth $17,231,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also recently bought and sold shares of the business. USA Financial Formulas raised its position in shares of CVS Health by 573.2% in the 4th quarter. USA Financial Formulas now owns 377 shares of the pharmacy operator’s stock valued at $30,000 after purchasing an additional 321 shares in the last quarter. Ables Iannone Moore & Associates Inc. acquired a new stake in CVS Health in the fourth quarter valued at $32,000. First Community Trust NA boosted its stake in CVS Health by 116.2% during the 2nd quarter. First Community Trust NA now owns 562 shares of the pharmacy operator’s stock valued at $33,000 after acquiring an additional 302 shares during the last quarter. Creekmur Asset Management LLC bought a new stake in shares of CVS Health in the 4th quarter worth about $34,000. Finally, Steph & Co. raised its stake in shares of CVS Health by 192.0% in the 1st quarter. Steph & Co. now owns 438 shares of the pharmacy operator’s stock valued at $35,000 after purchasing an additional 288 shares in the last quarter. Hedge funds and other institutional investors own 80.66% of the company’s stock.

CVS Health Stock Performance

CVS opened at $57.75 on Friday. The business has a 50 day moving average price of $58.29 and a two-hundred day moving average price of $63.78. The company has a debt-to-equity ratio of 0.83, a current ratio of 0.86 and a quick ratio of 0.66. The company has a market capitalization of $72.50 billion, a price-to-earnings ratio of 10.15, a price-to-earnings-growth ratio of 0.80 and a beta of 0.53. CVS Health Co. has a 1-year low of $52.77 and a 1-year high of $83.25.

CVS Health (NYSE:CVS) last announced its quarterly earnings data on Wednesday, August 7th. The pharmacy operator reported $1.83 earnings per share for the quarter, beating the consensus estimate of $1.73 by $0.10. CVS Health had a return on equity of 12.72% and a net margin of 1.98%. The business had revenue of $91.23 billion during the quarter, compared to analyst estimates of $91.41 billion. During the same quarter in the prior year, the firm posted $2.21 earnings per share. The company’s revenue was up 2.6% on a year-over-year basis. Research analysts predict that CVS Health Co. will post 6.52 EPS for the current fiscal year.

CVS Health Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Thursday, August 1st. Shareholders of record on Monday, July 22nd were issued a $0.665 dividend. The ex-dividend date of this dividend was Monday, July 22nd. This represents a $2.66 annualized dividend and a dividend yield of 4.61%. CVS Health’s dividend payout ratio is currently 46.75%.

Wall Street Analyst Weigh In

A number of equities analysts recently commented on CVS shares. Evercore ISI decreased their price target on CVS Health from $65.00 to $62.00 and set an “outperform” rating for the company in a research note on Thursday, August 8th. Wells Fargo & Company boosted their price target on CVS Health from $60.00 to $61.00 and gave the company an “equal weight” rating in a report on Monday, August 12th. Royal Bank of Canada reissued an “outperform” rating and set a $68.00 price target on shares of CVS Health in a research report on Wednesday. Baird R W raised shares of CVS Health to a “hold” rating in a report on Thursday, May 30th. Finally, Barclays dropped their price target on CVS Health from $65.00 to $63.00 and set an “equal weight” rating on the stock in a research report on Thursday, August 8th. Eleven equities research analysts have rated the stock with a hold rating and twelve have given a buy rating to the stock. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $72.48.

About CVS Health

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.